Endogenous mediators in sepsis and septic shock
- PMID: 10086175
- DOI: 10.1016/s0065-2423(08)60206-1
Endogenous mediators in sepsis and septic shock
Similar articles
-
Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.Acta Pharmacol Sin. 2003 Oct;24(10):953-7. Acta Pharmacol Sin. 2003. PMID: 14531935 Review.
-
Nitric oxide in the pathogenesis of sepsis.Infect Dis Clin North Am. 1999 Jun;13(2):449-63, x. doi: 10.1016/s0891-5520(05)70085-4. Infect Dis Clin North Am. 1999. PMID: 10340177 Review.
-
Of mice and men (and rats): implications of species and stimulus differences for the interpretation of studies of nitric oxide in sepsis.Br J Anaesth. 2003 Feb;90(2):115-8. doi: 10.1093/bja/aeg033. Br J Anaesth. 2003. PMID: 12538363 No abstract available.
-
Vasoplegia in septic shock (review).Georgian Med News. 2015 Feb;(239):56-62. Georgian Med News. 2015. PMID: 25802451 Review.
-
[Physiopathology of severe sepsis].Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. doi: 10.1016/s0755-4982(04)98551-x. Presse Med. 2004. PMID: 15029017 Review. French.
Cited by
-
Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance.PLoS One. 2016 Apr 11;11(4):e0153282. doi: 10.1371/journal.pone.0153282. eCollection 2016. PLoS One. 2016. PMID: 27064683 Free PMC article.
-
Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.Br J Pharmacol. 2001 Aug;133(8):1371-7. doi: 10.1038/sj.bjp.0704202. Br J Pharmacol. 2001. PMID: 11498524 Free PMC article.
-
The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock.PLoS One. 2009 Aug 4;4(8):e6503. doi: 10.1371/journal.pone.0006503. PLoS One. 2009. PMID: 19652714 Free PMC article.
-
2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride inhibits microglial activation by suppression of nuclear factor-kappa B and mitogen-activated protein kinase signaling.J Neuroimmune Pharmacol. 2014 Sep;9(4):461-7. doi: 10.1007/s11481-014-9542-4. Epub 2014 Apr 22. J Neuroimmune Pharmacol. 2014. PMID: 24752390
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical